Lancet Study Says Pfizer, AstraZeneca Covid-19 Vaccines Provide Good Protection Against Delta Variant

Kathleen Kinder
Kathleen Kinder

Updated · Jun 29, 2021

SHARE: is supported by its audience. When you purchase through links on our site, we may earn an affiliate commission. Learn more.
Advertiser Disclosure

At Scoop, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Our data is available to the public free of charge, and we encourage you to use it to inform your personal or business decisions. If you choose to republish our data on your own website, we simply ask that you provide a proper citation or link back to the respective page on Scoop. We appreciate your support and look forward to continuing to provide valuable insights for our audience.

A new study has said that Pfizer and AstraZeneca Covid vaccines give protection against the Delta variant. The variant was first detected in India. It increases the risk of hospitalization than the Alpha variant. The Alpha variant was first detected in the UK. The study said that full doses of vaccines provide good protection. The study was conducted at Public Health Scotland and the University of Edinburgh. The study featured in Lancet. Researchers observed that vaccines are crucial in the fight against Covid-19. They found that the Pfizer-BioNTech vaccine provides better protection. The Oxford-AstraZeneca vaccine also works against the Delta variant. It is, however, less effective than Pfizer. The AstraZeneca vaccine is being given to people in India on large scale. It is called Covishield locally.

Researchers found that a complete dose of the Pfizer-BioNTech vaccine gives 79 percent protection against the Delta variant. The efficacy rate rises to 92 percent against the Alpha variant. The antibodies are produced after two weeks of the second dose. In the case of Oxford-AstraZeneca, the team said that the protection level against the Delta variant is 60 percent. It gives 73 percent protection against the Alpha variant. The study involved 20,000 people. They had SARS-CoV-2 infections. The study was done between April 1 and June 6. A total of 377 people were admitted to hospitals in Scotland. Researchers said that they found 7,700 community cases. A total of 134 people in hospitals were found to have the Delta variant Covid-19.

The study noted that two doses of vaccines provide better protection than a single dose against the Delta strain. The overall conclusion is that both vaccines effectively reduce the risk of severity due to the Delta variant. Several studies have said that the risk of hospital admission increases significantly in the Delta variant. The variant is dominant in India and parts of the UK. Researchers also noted that comparison between vaccines should be interpreted with caution. Meanwhile, the UK has delayed the Covid reopening. The country has delayed the plan by a month. The government has cited the rapid spread of the Delta variant as a reason to delay the plan. The Delta variant is 60 percent more transmissible than other strains.

Kathleen Kinder

Kathleen Kinder

With over four years of experience in the research industry, Kathleen is generally engrossed in market consulting projects, catering primarily to domains such as ICT, Health & Pharma, and packaging. She is highly proficient in managing both B2C and B2B projects, with an emphasis on consumer preference analysis, key executive interviews, etc. When Kathleen isn’t deconstructing market performance trajectories, she can be found hanging out with her pet cat ‘Sniffles’.